Imperial College London spin-out gets funding
Biopharmaceutical company PolyTherics has secured funding of £2.3 million from a consortium of private equity and venture capital interests.
News
Biopharmaceutical company PolyTherics has secured funding of £2.3 million from a consortium of private equity and venture capital interests.
News
News